Abstract：Objective To observe and explore the effectiveness of butylphthalide soft capsules (NBP) and nimodipine (NMD) in patients with vascular dementia (VD) after stroke.Methods A total of 96 patients with VD in General Hospital of Guangzhou Military Command were selected between May 2012 and August 2015. They were randomized into two groups of 48 patients: the NBP group and NMD group. The NBP group was treated orally with NBP while the NMD group was treated orally with NMD for 6 months respectively. The efficacy was evaluated by the cognitive function scale (MMSE, MOCA) and daily life ability scale (ADL score) before treatment and at 3 months and 6 months after treatment.The incidence of adverse reactions in both groups was recorded.Results The difference in MMSE, MOCA and ADL scores before treatment between the two groups was not statistically significant (P>0.05), but MMSE and MOCA scores in the NBP group were significantly higher than those of the NMD group 3 months and 6 months after treatment, , while ADL score was significantly lower than that of the NMD group (P＜0.01). The adverse reaction rate was 10.4% (5/48) and 22.9% (11/48) respectively in the NBP group, and 22.9% (11/48) in the NMD group. The difference was statistically significant (P＜0.05).Conclusion Both NBP and NMD treatment can significantly improve the cognitive function and daily life ability of VD patients, and the curative effect is remarkable, but NBP is more effective and safer than NMD.
程文姚，杨健，余新沛. 丁苯酞软胶囊与尼莫地平对卒中后血管性痴呆患者的疗效[J]. 解放军预防医学杂志, 2016, 34(4): 516-518.
CHENG Wenyao, YANG Jian, YU Xinpei. Effect of Butylphthalide Soft Capsules and Nimodipine on Patients with Vascular Dementia after Stroke. Journal of Preventive Medicine of Chinese People's Liberation Army, 2016, 34(4): 516-518.
(1) ZHANG X L,ZHENG S L,DONG F R,et al.Nimodipine improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia(J).Journal of International Medical Research,2012,40(3):1036. (2) 李强,沈琳娜.丁苯酞软胶囊联合尼莫地平治疗血管性痴呆的效果观察(J).中国综合临床,2013,29(6):606. (3) ZHANG L,LYU L,CHAN W M,et al.Effects of DL-3-n-butylphthalide on vascular dementia and angiogenesis(J).Neurochem Res,2012, 37(5):911. (4) 郑声浩.丁苯肽软胶囊用于缺血性脑卒中复发高危人群二级预防的临床疗效(J).浙江实用医学,2015,20(3):169. (5) 徐东升,黄伟,陈炜,等.丁苯酞软胶囊治疗急性脑梗死的临床疗效(J).临床合理用药杂志,2015,8(11):8. (6) 孙国兵,许康,赵薛旭,等.丁苯肽软胶囊对脑缺血大鼠神经保护作用研究(J).中华临床医师杂志(电子版),2013,7(10):4391. (7) 欧阳晓春,余小骊,张萃萍.丁苯肽软胶囊治疗血管性痴呆的疗效观察(J).东南国防医药, 2013,15(6):624. (8) 孙乐羽,李昕,牛延良,等.丁苯酞软胶囊治疗血管性痴呆的临床疗效(J).中国老年学杂志,2013,33(16):3967. (9) BASKYS A, CHENG J. Pharmacological prevention and treatment of vascular dementia: approaches and perspectives(J). Experimental gerontology, 2012,47(11):887. (10) WANG P,WANG Y,FENG T,et al.Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)(J).BMC neurology,2012,12(1):88. (11) 卢海丽,杨建芳,梁桂琴,等.丁苯酞软胶囊治疗血管性痴呆精神心理量表评分的变化及临床疗效观察(J).临床误诊误治,2011,24(3):35. (12) 夏德雨.丁苯酞与尼莫地平治疗脑卒中后血管性痴呆的对比观察(J).临床和实验医学杂志,2013,12(12):978. (13) SERIES H,ESIRI M.Vascular dementia:a pragmatic review(J).Advances in psychiatric treatment,2012,18(5):372. (14) BEISHON L C,HARRISON J K,HARWOOD R H,et al.The evidence for treating hypertension in older people with dementia: a systematic review(J).Journal of human hypertension,2014,28(5):283. (15) 杨申,梁迎春,颜秀梅,等.丁苯酞对血管性痴呆大鼠认知功能及海马细胞凋亡、磷酸化p38MAPK表达的影响(J).中华行为医学与脑科学杂志,2014,23(4):300. (16) 袁志华,丁琪,靳珊珊,等.丁苯酞治疗血管性痴呆疗效及安全性的系统评价(J).中华全科医学,2012,10(3):356. (17) VAN DE GLIND E M M,VAN ENST W A,VAN MUNSTER B C,et al.Pharmacological treatment of dementia: a scoping review of systematic reviews(J).Dementia and geriatric cognitive disorders,2013,36(3-4):211. (18) 邵小鹏,桂树华,胡玲玲,等.丁苯酞治疗老年血管性痴呆的临床疗效及对精神心理量表的影响(J).中国老年学杂志,2013,33(22):5601. (19) ZHANG L,LYU L,CHAN W M,et al.Effects of DL-3-n-butylphthalide on vascular dementia and angiogenesis(J).Neurochemical research, 2012,37(5):911. (20) WEI W,ZHANG W,HUANG Y,et al.The therapeutic effect of DL-3-n-butylphthalide in rats with chronic cerebral hypoperfusion through downregulation of amyloid precursor protein and matrix metalloproteinase-2(J).Journal of International Medical Research,2012,40(3):967.
No related articles found!
Viewed
Full text
Abstract
Cited
Shared
Discussed
[an error occurred while processing this directive]
2016, Vol. 34 
